The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
145
Unnamed facility
Miami, Florida, United States
Unnamed facility
Pinellas Park, Florida, United States
Unnamed facility
West Palm Beach, Florida, United States
Unnamed facility
Chicago, Illinois, United States
Investigators Global Assessment Scale
Crow's Feet Wrinkle Scale
Time frame: Week 4
Subject Self-Assessment score
Subjects self assessment of severity of Crow's Feet
Time frame: up to 12 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Metairie, Louisiana, United States
Unnamed facility
New Orleans, Louisiana, United States
Unnamed facility
Rochester, New York, United States
Unnamed facility
High Point, North Carolina, United States
Unnamed facility
Knoxville, Tennessee, United States
Unnamed facility
Norfolk, Virginia, United States